Lee Wen-Ling, Chang Wen-Hsun, Wang Kuan-Chin, Guo Chao-Yu, Chou Yiing-Jeng, Huang Nicole, Huang Hsin-Yi, Yen Ming-Shyen, Wang Peng-Hui
From the Department of Nursing, Oriental Institute of Technology, New Taipei City (W-LL, K-CW); Department of Medicine, Cheng-Hsin General Hospital (W-LL); Department of Obstetrics and Gynecology (W-LL, M-SY, P-HW); Department of Nursing (W-LL, W-HC, P-HW); Institute of Hospital and Health Care Administration and Institute of Public Health, National Yang-Ming University, Taipei, Taiwan (C-YG, Y-JC, NH); Department of Nursing (W-HC); Department of Obstetrics and Gynecology (W-HC, M-SY, P-HW); Biostatics Task Force, Taipei Veterans General Hospital, Taipei, Taiwan (H-YH); Department of Medical Research (P-HW); and China Medical University Hospital, Taichung, Taiwan.
Medicine (Baltimore). 2015 Sep;94(39):e1633. doi: 10.1097/MD.0000000000001633.
This article aims to test the hypothesis that the risk of epithelial ovarian cancer (EOC) in women with endometriosis might be changed by enrolling different population. A nationwide 14-year historic cohort study using the National Health Insurance Research Database (NHIRD) of Taiwan and the Registry for Catastrophic Illness Patients was conducted. A total of 239,385 women aged between 20 and 51 years, with at least 1 gynecologic visit after 2000, were analyzed. Cases included women with a diagnosed endometriosis, which was established along a spectrum from at least 1 medical record of endometriosis (recalled endometriosis) to tissue-proved ovarian endometriosis (n = X). Controls included women without any diagnosis of endometriosis (n = 239,385 - X). We used Cox regression, and computed hazard ratios (HRs) with 95% confidence intervals (95% CI) to determine the risk of EOC in patients. The EOC incidence rates (IRs, per 10,000 person-years) of women with endometriosis ranged from 1.90 in women with recalled endometriosis to 18.70 in women with tissue-proved ovarian endometrioma, compared with those women without any diagnosis of endometriosis (0.77-0.89), contributing to crude HRs ranging from 2.59 (95% CI, 2.09-3.21; P < 0.001) to 24.04 (95% CI, 17.48-33.05; P < 0.001). After adjustment for pelvic inflammatory disease, infertility, Charlson co-morbidity index, and age, adjusted HRs were ranged from the lowest of 1.90 (95% CI, 1.51-2.37; P < 0.001) in recalled endometriosis to the highest of 18.57 (95% CI, 13.37-25.79; P < 0.001) in tissue-proved ovarian endometrioma, which was inversely related to the prevalence rate of endometriosis (from the highest of 30.80% in recalled endometriosis to the lowest of 1.54% in tissue-proved ovarian endometrioma). The risk of EOC in women with endometriosis varied greatly by different criteria used. Women with endometriosis might have a more apparently higher risk than those reported by systematic review and meta-analysis.
纳入不同人群可能会改变子宫内膜异位症女性患上皮性卵巢癌(EOC)的风险。我们利用台湾地区国民健康保险研究数据库(NHIRD)和重大伤病患者登记系统进行了一项为期14年的全国性历史性队列研究。共分析了239,385名年龄在20至51岁之间、2000年后至少有1次妇科就诊记录的女性。病例包括被诊断为子宫内膜异位症的女性,其诊断范围从至少1份子宫内膜异位症病历记录(回忆性子宫内膜异位症)到组织学证实的卵巢子宫内膜异位症(n = X)。对照包括未被诊断为任何子宫内膜异位症的女性(n = 239,385 - X)。我们使用Cox回归分析,并计算风险比(HRs)及95%置信区间(95% CI)来确定患者患EOC的风险。与未被诊断为任何子宫内膜异位症的女性(0.77 - 0.89)相比,子宫内膜异位症女性的EOC发病率(IRs,每10,000人年)从回忆性子宫内膜异位症女性的1.90到组织学证实的卵巢子宫内膜异位瘤女性的18.70不等,粗风险比范围为2.59(95% CI,2.09 - 3.21;P < 0.001)至24.04(95% CI,17.48 - 33.05;P < 0.001)。在对盆腔炎、不孕症、Charlson共病指数和年龄进行调整后,调整后的风险比范围从回忆性子宫内膜异位症中最低的1.90(95% CI,1.51 - 2.37;P < 0.001)到组织学证实的卵巢子宫内膜异位瘤中最高的18.57(95% CI,13.37 - 25.79;P < 0.001),这与子宫内膜异位症的患病率呈负相关(从回忆性子宫内膜异位症中最高的30.80%到组织学证实的卵巢子宫内膜异位瘤中最低的1.54%)。根据不同的诊断标准,子宫内膜异位症女性患EOC的风险差异很大。子宫内膜异位症女性的风险可能比系统评价和荟萃分析报告的风险明显更高。